Aileron Therapeutics

Aileron Therapeutics

Clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases.

HQ location
Cambridge, United States
Website
Launch date
Employees
Market cap
$40.3m
Enterprise value
$40m
Share price
$1.40 ALRN
Recent deals
Authorizing premium user...